TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis
Carregando...
Data
Data de publicação
Autores IPEN
Orientador
Título da Revista
ISSN da Revista
Título do Volume
É parte de
É parte de
É parte de
Clinical Immunology
ODS
Exportar
Resumo
Experimental Allergic Encephalomyelitis (EAE) is a neuroinflammatory, autoimmune disorder in which myelin-reactive Th1 T cells with a restricted TCRVβ repertoire play a pathogenic role. Here, I show that an engineered single-chain TCR containing dominant TCRVα/Vβ encephalitogenic elements, when administered in aluminum adjuvant, generates a marked anti-TCR humoral response that correlated with protection against the development of EAE in Vβ8-expressing B10.PL but not in Vβ8-deficient SJL mice. sc-TCR/Al vaccination was highly efficient in preventing murine EAE in a TCR-specific manner through a mechanism involving anti-TCR B cells and/or antibodies. Collectively, these data have important implications for designing preventive or therapeutic strategies combining TCR vaccination with the use of aluminum adjuvant in the treatment of multiple sclerosis and other human autoimmune inflammatory diseases.
Como referenciar
AROEIRA, LUIZ S. TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis. Clinical Immunology, v. 119, n. 3, p. 252-260, 2006. DOI: 10.1016/j.clim.2006.01.003. Disponível em: https://repositorio.ipen.br/handle/123456789/48182. Acesso em: 30 Dec 2025.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.